Loading…
Loading…
THCT does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for THCT and 80,000+ other tickers.
See exactly how THCT's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for THCT and 80,000+ other tickers.
THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.
Company Strengthens Reporting Compliance and Accelerates Growth Through Strategic Cannabis Sector Acquisitions Jacksboro, Texas, March 3, 2025 – PRISM MediaWire (Press Release Service – Press Release Distribution) – THC Therapeutics, Inc. (OTC: THCT), a dynamic and growing cannabis company, issued a shareholder update today.
Ten-Year Legacy Brand Joins THCT Portfolio, Expanding National Craft Cannabis Footprint and Female-Founded Leadership Medford, OR, July 8, 2025 – PRISM MediaWire – THC Therapeutics, Inc.
Breakthrough Transaction Unites Segment Leaders into a Powerful and Flexible Player in the Legal Cannabis Industry Medford, OR, June 24, 2025 – PRISM MediaWire – THC Therapeutics, Inc.
MEDFORD, Ore., June 24, 2025 (GLOBE NEWSWIRE) -- THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the emerging and dynamic legal and regulated cannabis industry, announced today that it has acquired all of the issued and outstanding ownership interests of The Headquarters Group, Inc. (“THG”) in an all-share transaction valued at approximately $11,000,000 (the "Transaction") and completely satisfied through the issuance of 11,007 thousand shares of newly created Series D Preferred stock.
Cannabis-focused technology company THC Therapeutics, Inc. (OTCMKTS: THCT) revealed Friday that it has secured up to $50 million in funding from Shefford Capital Partners for acquisitions in the cannabis, alternative therapies and modern health space. Shefford Capital Partners is a private equity firm presently managing over $250 million in capital.